A QUANTIZYME® Assay System. The MMP-3 Fluorometric (also known as fluorimetric) Drug Discovery Kit is a complete assay system designed to screen inhibitors of matrix metalloproteinase-3 (MMP-3, stromelysin-1) using a quenched fluorogenic peptide: OMNIMMP® fluorogenic substrate Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH. Mca fluorescence is quenched by the Dpa group until cleavage by MMPs at the Gly-Leu bond separates the two moieties. The assays are performed in a convenient 96-well microplate format. The kit is useful to screen inhibitors of MMP-3, a potential therapeutic target. Included are active enzyme, assay buffer, a prototypic control inhibitor (NNGH3), and a detailed instruction booklet.
Product Details
| Alternative Name: | Stromelysin-1, Transin-1 |
| |
| Applications: | Fluorescent detection, HTS
Activity assay
|
| |
| Shipping: | Shipped on Dry Ice |
| |
| Long Term Storage: | -80°C |
| |
| Contents: | MMP-3 enzyme (human) (recombinant), substrate, calibration standard, inhibitor, assay buffer, 96-well white microplate. |
| |
| UniProt ID: | P08254 |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Photocontrol of Peptide function: backbone cyclization strategy with photocleavable amino Acid: N. Umezawa, et al.; Chembiochem
12, 1694 (2011),
Abstract;
Hippocampal MMP-3 elevation is associated with passive avoidance conditioning: M.L. Olson, et al.; Regul. Pep.
146, 19 (2008),
Abstract;
